Anlotinib Combined with Etoposide as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

被引：0
|
作者：
Shen, B. [1 ]
Wu, Y. [2 ]
Shi, L. [1 ]
Feng, J. [1 ]
机构：
[1] Jiangsu Canc Hosp, Nanjing, Peoples R China
[2] Jiangsu Canc Hosp, Med Oncol, Nanjing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Anlotinib; Etoposide; Extensive-stage small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P48.24
引用
收藏
页码：S509 / S510
页数：2
相关论文
共 50 条
  • [1] Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study
    Kong, Tiandong
    Chen, Lu
    Zhao, Xiaoli
    Duan, Fangfang
    Zhou, Hanli
    Wang, Lei
    Liu, Danna
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (05) : 1095 - 1105
  • [2] Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study
    Tiandong Kong
    Lu Chen
    Xiaoli Zhao
    Fangfang Duan
    Hanli Zhou
    Lei Wang
    Danna Liu
    Investigational New Drugs, 2022, 40 : 1095 - 1105
  • [3] Carrelizumab combined with anlotinib in the treatment of extensive-stage small cell lung cancer A case report
    Liu, Liang
    Zhang, Xin
    Zhou, Lihua
    Yang, Tao
    Qiao, Yun
    Jiang, Xiaodong
    MEDICINE, 2021, 100 (35) : E27138
  • [4] Toripalimab and anlotinib as a maintenance treatment for extensive-stage small-cell lung cancer: a case report
    Wu, Guixian
    Huang, Jing
    Lin, Ling
    Yan, Shuangquan
    Pan, Weijia
    Chen, Qian
    Wu, Xiaomai
    Lv, Dongqing
    IMMUNOTHERAPY, 2022, 14 (13) : 1007 - 1013
  • [5] Cisplatin Combined with Irinotecan or Etoposide for Untreated Extensive-Stage Small Cell Lung Cancer
    Shi, Yuankai
    Hu, Xingsheng
    Hu, Yi
    Han, Xiaohong
    Li, Xue
    Lin, Lin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S625 - S625
  • [6] Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting?
    Elijah, Joseph
    Jain, Prantesh
    Holdsworth, Allison
    Baron, Jeffrey
    Przespolewski, Eugene
    Wang, Katy
    Attwood, Kristopher
    Billias, Christina
    Dy, Grace K.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (09)
  • [7] Toripalimab combined with anlotinib for recurrent extensive-stage small-cell lung cancer: A case report
    Wu, Ying
    Chen, Yinqiao
    Yang, Zhouliang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (01)
  • [8] Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial
    Wu, Yuan
    Zhou, Xuefeng
    Zhao, Weiqing
    Wang, Qiong
    Han, Zhengxiang
    Wang, Lifeng
    Zhou, Wenjie
    Zhou, Tong
    Song, Haizhu
    Chen, Yong
    Yang, Kaihua
    Shi, Lin
    Pan, Banzhou
    Guo, Renhong
    Zhou, Guoren
    Jiang, Feng
    Feng, Jifeng
    Shen, Bo
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (06) : 825 - 833
  • [9] Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial
    Yuan Wu
    Xuefeng Zhou
    Weiqing Zhao
    Qiong Wang
    Zhengxiang Han
    Lifeng Wang
    Wenjie Zhou
    Tong Zhou
    Haizhu Song
    Yong Chen
    Kaihua Yang
    Lin Shi
    Banzhou Pan
    Renhong Guo
    Guoren Zhou
    Feng Jiang
    Jifeng Feng
    Bo Shen
    Investigational New Drugs, 2023, 41 : 825 - 833
  • [10] Anlotinib Plus Toripalimab as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer: a Single-Arm Phase II Study
    Lv, D.
    Wu, G.
    Lin, L.
    Yan, S.
    Wu, X.
    Pan, W.
    Huang, J.
    Gao, Z.
    Gu, Q.
    Li, H.
    Chen, Q.
    Lin, W.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S533 - S533
12345